The augmentation index (AIx) is a measure of systemic arterial stiffness, and previous studies have demonstrated an association between AIx and risk factors of cardiovascular disease (CVD). However, there is limited knowledge about the age and gender differences of the observed associations. Therefore, the aim of the present study is to examine the association's consistency at different ages and to see if the associations are the same in men and women. This study is based on 3432 subjects from The Copenhagen City Heart Study, a prospective epidemiological survey of a representative population in Denmark. All subjects had AIx measured non-invasively by the SphygmoCor device (SphygmoCor, West Ryde, Australia). To analyse the association between AIx and CVD risk factors multiple linear regression analyses were used stratified by gender and age.
Introduction
Arterial stiffness reflects arterial compliance and is a major reason for increased systolic blood pressure and pulse pressure with age leading to increased risk of cardiovascular disease (CVD). 1 In recent years, techniques have been developed to examine the compliance of the central arteries non-invasively where pulse wave velocity (PWV) is considered the gold standard of measuring arterial stiffness, while the aortic augmentation index (AIx) is a measure of pulse wave reflections.
2 PWV and AIx provide two different measures of the properties of the arterial tree that cannot be used interchangeably, 2 and AIx may have advantages compared with PWV. AIx is fairly easily measured by applanation tonometry and therefore less time consuming than measuring PWV; 2 in addition, AIx may be modifiable to a higher degree than PWV. 3, 4 However, concerns have been raised as to whether AIx is a reliable measurement of vascular compliance in the elderly 5, 6 due to the curvilinear association between AIx and age. 6, 7 Interestingly, findings have been contradictory regarding AIx as predictor of CVD where AIx has been associated with increased risk of CVD in highrisk populations 8, 9 and in men, 10, 11 while its use as a predictor in women 12, 13 and in the general population is less certain. 13, 14 The association between AIx and traditional CVD risk factors has been analysed in several studies with different methodology and various findings. [15] [16] [17] [18] Recently, a large study of subjects from the general population reported that associations between AIx and CVD risk factors are dependant of age, and that age had a larger influence on AIx than traditional CVD risk factors. 19 However, no gender differences were reported.
It is possible that the inconsistent predictive value of AIx between genders and populations can be explained by different associations between AIx and CVD risk factors in genders and different age compositions of populations. AIx may be an intermediate marker of CVD reflecting the influence of traditional CVD risk factors on the arterial wall or, in contrast AIx may be an independent risk factor for CVD making AIx a predictor of CVD in addition to known CVD risk factors.
The aim of this study was to examine the associations between AIx measured non-invasively by the SphygmoCor device and CVD risk factors in a large normal population, and to explore the impact of gender and age on the association between AIx and risk factors of CVD.
Methods
This cross-sectional study is based on data from The Copenhagen City Heart Study, an ongoing epidemiological survey started in 1976, complying with the Declaration of Helsinki and approved by the Local Ethics Committee. The fourth survey took place between September 2001 and July 2003 and 12 600 subjects, randomly chosen from the Danish general population in Copenhagen by use of the Danish civil registration number were invited. The overall response rate was 50%, which resulted in the examination of 2660 men and 3577 women between the age of 20 and 97 years. After giving written informed consent the participants filled out a questionnaire about lifestyle including physical activity, alcohol consumption, smoking habits, previous diseases, symptoms, medication and education. A physical examination was performed including assessments of blood pressure measured once in the left upper arm after 5 min of rest using a London School of Hygiene sphygmomanometer and pulse wave analysis (PWA). A non-fasting venous blood sample was analysed for plasma levels of glucose, high-sensitive C-reactive protein (hs-CRP), total cholesterol, high-density lipoprotein, lowdensity lipoprotein and triglycerides. Non-fasting measures of lipoprotein and triglycerides have been shown to be as good a predictor of CVD events as fasting measurements. 20 Hs-CRP and triglycerides were log transformed to achieve normality.
Weekly alcohol intake was categorised in four groups: None; light: o7 units; medium: 7-14 units (women) 7-21 units (men); high: 414 units (women) 21 units (men). Smoking status was categorised as never smokers, ex-smokers (if they had ever smoked) or current smokers. Education was defined as short if subjects had p3 years of education after secondary school and was otherwise defined as long. Physical activity was defined as more then 4 h of physical activity (fast walking or biking or exercise that makes you breathless) per week. Diabetes (yes/no) was defined by either selfreported disease or self-reported use of anti-diabetic medication. Subjects were predisposed to CVD if any of their parents had suffered from a myocardial infarction or a stroke. Hypertension was defined as blood pressure 4140/90 mm Hg measured at the physical examination or self-reported use of antihypertensive medication. Hypercholesterolaemia was defined as total cholesterol 47 mM if no previous CVD, 44.5 mM if previous stroke or myocardial infarction, 44 mM if subjects had diabetes or if subjects had self-reported use of anticholesterol medication. Information on previous CVD was obtained through register linkage with the Danish National Hospital Discharge Register, which covers all hospital discharges from 1977 onwards.
AIx was measured by PWA. Radial artery pulse waves were recorded non-invasively by applanation tonometry with a high-fidelity micromanometer (SPT-301B Miller Instruments, Houston, TX, USA). The peripheral pulse waves were captured and PWA (SphygmoCor, West Ryde, Australia) was used to derive a central aortic pulse wave and hemodynamic measures by a generalised validated mathematical transfer function. [21] [22] [23] The central augmented pressure is the difference between the maximum systolic peak on the aortic pulse wave and the inflection point, the latter is defined as the merging point for the incident and reflected wave. The AIx is expressed as the augmented pressure as a percentage of the central pulse pressure. Trained laboratory technicians measured PWA on subjects in a seated position after 5 min of rest. Unfortunately, PWV was not measured in the Copenhagen City Heart Study.
AIx was measured in 4561 subjects but not all of them had equal numbers of measurements; some had several (up to five) measurements taken during the one visit to the clinic. We chose to use only AIx measurements with the highest quality. We assigned each measurement a quality score from 0 to 4 indicating how many of the following criteria were met: pulse height more than 100 units, pulse height variation and diastolic variation less than 5% and pressure peak between 80 and 150 ms from the start of the wave. If subjects had two or more measurements of good quality, the mean of these was used in the analyses. AIx measurements in 1129 subjects were of unacceptable quality with a quality score p1 and were excluded. The SphygmoCor device has an inbuilt quality index comprised of a weighted index of the first three quality criteria listed above. The weighting factor to calculate the quality index was unknown and the quality index was only available during measurement and not exported in the data sheet in our study, and we therefore used the method described above to estimate the quality of the measurements.
Statistical analyses
Differences in CVD risk factors between subjects with high vs. low AIx (separated by the median) in different age groups were examined using twosample t-test for continuous variables and w 2 -test for categorical variables. To investigate the association between AIx and risk factors of CVD, we used different multiple linear regression models. AIx was the dependant variable and age, heart rate, height, weight, systolic blood pressure, diastolic blood pressure, total cholesterol, low-density lipoprotein, high-density lipoprotein, log-triglycerides, log-high sensitive C-reactive protein (log-hsCRP) smoking status, years of smoking, weekly alcohol consumption, diabetes (yes/no), physical activity, predisposition to CVD and education as covariates. The influence of age and gender on the association between AIx and CVD risk factors was analysed by constructing interaction terms between CVD risk factor and age, and gender, respectively, using two approaches. First we included all subjects in one model analysing for interaction by gender and age using age as a continuous variable in the interaction terms. Three-way interaction terms between age Â gender Â CVD risk factor were also included.
In the light of the earlier reported curvilinear association between AIx and age with AIx reaching a plateau after approximately 60 years of age 6, 7 and the higher AIx in women, 24 we chose to analyse for interaction by age using age as a dichotomous variable in the interaction terms (young o60 years; old X60 years) in gender-separated analyses. Finally four models stratified by age (young/old) and gender were analysed and age, heart rate and height were included in every model. Age 2 was included as a covariate due to the curvilinear association between AIx and age and kept in the model if significant. If a CVD risk factor variable was significant in one of the models, the variable was included in all of the four regression models for comparison. The analyses including women were also adjusted for menopause (yes/no) and hormonal replacement (yes/no). Data on CVD risk factors were missing in 148 women and 129 men.
Explanatory variables with a two-sided P-value o0.05 were considered significant. As some AIx values were the result of the means of two or more AIx measurements and had different quality scores, all multiple regression analyses were weighted by a covariate indicating quality and how many measurements were used to calculate the means of AIx. To estimate the weights, generalised least squares method was used.
All the analyses were performed with the statistical package STATA 10 (STATA SE 10.0 for windows, Collage Station, TX, USA).
Results
The characteristics of the study population are summarised in Tables 1A and 1B. The median of AIx was 17 in men o60 years, 28 in men X60 years, 26 in women o60 years and 36 in women X60 years. For both genders the differences in CVD risk factors between groups with high vs. low AIx were more pronounced in subjects younger than 60 years than in the elderly.
Influence of age and gender on the relationship between AIx and CVD risk factors In the model including all subjects we found statistically significant interaction with age in the association between AIx and height, diastolic blood pressure, cholesterol, education, and physical activity and gender interaction on the relationship between AIx and age, and systolic blood pressure. Additionally both age and gender had influence on the association between current smoking and AIx and high alcohol consumption and AIx (Supplementary Table in supplement) (Figures 1 and 2) .
Figures 3 and 4 show the curvilinear association between age and AIx in both genders and supports the stratification point of 60 years, as the curves reach a plateau approximately at this age. Further, in multiple linear regression analyses analysing interaction with a dichotomous age variable we found significant interaction with age (o60/X60 years) for the same covariates: in men for diastolic blood pressure (P for interaction ¼ 0.03), education (P ¼ 0.002) and physical activity (P ¼ 0.01); in women, for height (P ¼ 0.04), diastolic blood pressure (P ¼ 0.02), cholesterol (P ¼ 0.001) and smoking status (Po0.001).
The gender differences in the association between AIx and age found in all subjects were replicated in subjects younger than 60 years, with AIx having a more curvilinear association with age in women than in men (interaction between gender and age 2 P ¼ 0.002). Furthermore, hs-CRP was associated with AIx in men but not in women (P for interaction ¼ 0.02) in this younger part of the population. In subjects more than 60 years, gender differences were found in the associations AIx/ systolic blood pressure (P for interaction ¼ 0.003) and AIx/current smoking (P for interaction ¼ 0.03).
The impact of CVD risk factors on AIx
AIx was associated with several of the traditional CVD risk factors in subjects younger than 60 years (Table 2) . AIx was positively associated with blood pressure, total cholesterol, hs-CRP and smoking, and negatively associated with higher education and high physical activity. Systolic blood pressure had the highest effect on AIx of the CVD risk factors (Table 2) . However, age together with the heart rate and height explained a large part of the variation in AIx (adjusted R 2 for men ¼ 31.1 out of a total R 2 ¼ 42.1, and for women ¼ 40.1 out of a total R 2 ¼ 49.4). There was no association between AIx and diabetes, triglycerides, high-density lipopro-tein, low-density lipoprotein, years of smoking or predisposition to CVD. In women we found no relationships between AIx and menopause or hormonal replacement.
In the elderly, AIx was positively associated with systolic blood pressure in both genders, diastolic blood pressure in women and current smoking and age in men. AIx was negatively associated with heart rate, height and weight in both genders (Table 3 ). In this age group age, heart rate and height together with systolic blood pressure explained the majority of the variation in AIx (men: R 2 ¼ 31.7 of 33.7. women: R 2 ¼ 23.5 of 24.6). The association between AIx and high alcohol consumption was complex. In younger men high alcohol consumption was associated with decreased AIx, while in younger women the opposite was seen (Figure 2 ). High alcohol consumption did not show any statistically significant association with AIx in any of the four age-and gender-stratified models.
Discussion
AIx was associated with many of the traditional CVD risk factors in younger subjects from a general population. However, age, heart rate and height together with systolic blood pressure had a higher impact on AIx than other traditional CVD risk factors. The modest effects of CVD risk factors on AIx were influenced by age more than gender so despite higher risk of CVD in the elderly, fewer CVD risk factors were associated with AIx in this age group with some gender differences. This suggests that AIx is far from solely determined by the influence from traditional CVD risk factors on the arterial wall especially in the elderly part of our population.
That AIx is highly influenced by age, heart rate, height and systolic blood pressure and that the contribution of other CVD risk factors is small, is in agreement with the results found by McEneiry and The P-value for comparison between high and low AIx group. AIx is separated by the median in each age-group; 17 for men o60 years and 28 for men X60. Diabetes was based on either self-reported disease or self-reported use of anti-diabetic medication. Subjects were predisposed to CVD if any of their parents had suffered from a myocardial infarction (MI) or a stroke. Hypertension was defined as blood pressure 4140/90 or selfreported use of anti-hypertensive medication. Hypercholesterolaemia was defined as total cholesterol 47 mM if no previous CVD or 44.5 mM if previous stroke or myocardial infarction or 44 mM if subjects had diabetes or self-reported use of anti-cholesterol medication.
co-workers 19 in 4421 subjects from the Anglo-Cardiff Collaborative Trial. A systematic review examining the strength of the association between PWV and CVD risk factors found similarly that PWV was influenced by age and blood pressure more than by other CVD risk factors. 25 Regardless of the modest relationship, AIx was associated with more of the traditional CVD risk factors in younger subjects compared with the elderly in our population. McEniery and co-workers 19 reported dependency of age in the association between AIx and systolic blood pressure, diastolic blood pressure and smoking. In comparison, we also found the relationship between AIx and education, physical activity, height and total cholesterol to be dependant of age. Moreover, the dependency of age on some of the CVD risk factors associations with AIx differed between genders in our study. Van Trijp and co-workers 15, 26, 27 examined determinants of AIx in 500 young and The P-value for comparison between high and low AIx group. AIx is separated by the median in each age-group; 26 for women o60 years and 34 for women X60. Diabetes was based on either self-reported disease or self-reported use of anti-diabetic medication. Subjects were predisposed to CVD if any of their parents had suffered from a myocardial infarction (MI) or a stroke. Hypertension was defined as blood pressure 4140/90 or self-reported use of anti-hypertensive medication. Hypercholesterolaemia was defined as total cholesterol 47 mM if no previous CVD or 44.5 mM if previous stroke or myocardial infarction or 44 mM if subjects had diabetes or self-reported use of anti-cholesterol medication. Figure 1 The beta-coefficients from multiple regression analysis showing the association between AIx and current smoking broken down by age and gender.
The augmentation index association with cardiovascular risk factors JH Janner et al 300 middle-aged subjects from two different Dutch normal populations. They found AIx to be positively associated with blood pressure, cholesterol and smoking and negatively with heart rate and height, but found no effect of physical activity. These associations were more pronounced in their youngest population. 26 One explanation for the observed age differences can be found in the definition of the AIx. AIx has a curvilinear increase with age, and after approximately 60 years of age the AIx levels of and reaches a plateau. 6, 7 This curve shape could indicate a decrease in pulse wave reflection in the elderly. 28 However, Namasivayam and co-workers 29 hypothesised that the attenuation of AIx is due to a larger contribution of the incident pressure wave to the increasing pulse pressure with age and not a decrease in pulse wave reflection. The incident pressure wave increases as the central arteries get stiffer and loose compliance. The plateau phase of AIx in subjects more than 60 years of age can explain why the association between AIx and CVD risk factors is attenuated in the elderly even though the vascular compliance keeps decreasing with age. However, we cannot rule out that selection bias also has a role, as subjects with high risk of CVD are less likely to become old.
Whether the association between AIx and CVD risk factors differs by gender is poorly described. Van Trijp and co-workers 26 found almost no difference in determinants of AIx between genders, while two other studies found different CVD risk factors as explanatory variables of AIx in men compared with women. 30, 31 In agreement with the literature, 6,26 AIx was significantly higher in women than in men in our study and we found some gender differences in the association between AIx, age, systolic blood pressure, current smoking, high alcohol consumption and hs-CRP. In the young age group age-squared was a significant determinant of AIx in women but not in men, which is consistent with an earlier plateau phase of the AIx/age curve in women (Figures 3 and 4) . Hs-CRP was associated with AIx in young men but not in young women. Systemic inflammation stimulates the age-dependant breakdown of elastic fibres and replacement by collagen in the central elastic arteries. 32 Most studies have reported an association between arterial stiffness measured by AIx 33, 34 and high levels of markers of inflammation including hs-CRP, although some only found hs-CRP to be associated with PWV. 35 Current smoking was associated with at higher AIx in young women compared with young men and also with a faster attenuation of this relationship with increasing age in women compared with men. Smoking has rather consistently been associated with increased AIx. 15, 18, 36, 37 In our study, AIx was only associated with high alcohol consumption with a complex interaction by gender and age. Thus, our result differs from the J-shaped relationship between AIx and alcohol consumption in men, and others have found that high alcohol consumption was associated with high AIx. 38 We are, however, not aware of studies indicating gender Figure 2 The beta-coefficients from multiple regression analysis showing the association between AIx and high alcohol consumption broken down by age and gender. Figure 3 The association between AIx and age in men with 95% prediction interval. Figure 4 The association between AIx and age in women with 95% prediction interval.
The augmentation index association with cardiovascular risk factors JH Janner et al differences neither in the hs-CRP/AIx, alcohol consumption/AIx nor in the current smoking/AIx association. We found no explanatory influence of status of menopause or hormonal replacement in women in our study. Further studies are needed to replicate and subsequently understand the difference between genders in the association between AIx and hs-CRP, current smoking and high alcohol consumption.
The strength of our study is the large sample size enabling us to compare the association between AIx and CVD risk factors between younger and elderly subjects and between genders. Furthermore, we have comprehensive information on CVD risk factors. We presented data in gender and agestratified analyses with a cut point of 60 years for a more understandable interpretation of the results. The choice of 60 years was pragmatic and based on Significant interaction with gender (P ¼ 0.003 for systolic blood pressure, P ¼ 0.03 for current smoking).
The augmentation index association with cardiovascular risk factors JH Janner et al our previous work, 7 from inspection of the AIx/age curve, and based on the literature. 29 The statistically significant interaction terms found in the large model using age as a continuous variable in the interaction terms were comparable to the interaction terms found in the age-and gender-stratified analyses, and supports the results found in these four analyses. However, the choice of a cut point can affect the results as seen with hs-CRP where we found interaction with gender in subjects o60 years but no gender interaction in the large model. A limitation of the study is the fact that the calculation of the central pulse wave from the radial pulse wave using a generalised transfer function has been criticised and is still debated. 22, 39, 40 It seems that the use of the generalised transfer function is valid when the construction of the central pulse wave from the radial pulse wave is calibrated to invasively measured blood pressures, but can be a problem when brachial blood pressure is used for calibration as in the SphygmoCor device. 2, 39 Unfortunately, the information on medication was very unspecific and we therefore chose not to adjust the associations observed for use of medication. We are aware that medication for hypertension can influence AIx. However, two of the most common classes of medicine used for hypertension, beta-blockers and ACE-inhibitors, have opposite effects on AIx 3 and it would be difficult to draw any useful conclusions from analyses adjusting for anti-hypertensive medication (yes/no).
In conclusion, this study shows a modest association between CVD risk factors and AIx which is further attenuated in subjects 460 years. Age, heart rate, height and systolic blood pressure were the main determinants of AIx and despite some significant gender differences this was consistently seen in both men and women. This indicates that AIx may be an independent risk factor for CVD more than an intermediate marker between traditional CVD risk factors and CVD. However, the future role for AIx as a screening tool for CVD risk in clinical practise, both in the young and the elderly, needs to be examined in longitudinal studies of healthy subjects before any firm recommendations can be made.
